Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Found 5426 publications
2017-2022 United States Bacterial Vaginosis Drug Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... , the Bacterial Vaginosis Drug market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the ...

Nov, 2017 124 pages
2017-2022 United States Alzheimer’s Disease Drug Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... , the Alzheimer’s Disease Drug market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the ...

Nov, 2017 119 pages
2017 Top 5 Bacterial Vaginosis Drug Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa US$ 4,960.00 US$ 4,365.00

... on the top 5 Bacterial Vaginosis Drug players in each region, with sales, price, revenue and market share from 2012 to 2017, the top players ... , this report focuses on sales, market share and growth rate of Bacterial Vaginosis Drug in each application, can be divided into Hospital Pharmacy Other

Nov, 2017 124 pages
2017 Top 5 Alzheimer’s Disease Drug Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa US$ 4,960.00 US$ 4,365.00

... on the top 5 Alzheimer’s Disease Drug players in each region, with sales, price, revenue and market share from 2012 to 2017, the top players ... , this report focuses on sales, market share and growth rate of Alzheimer’s Disease Drug in each application, can be divided into Early to Moderate Stages ...

Nov, 2017 119 pages
2017-2022 North America Bacterial Vaginosis Drug Market Report US$ 4,660.00 US$ 4,100.00

... will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in North America market, especially in United States, ... North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...

Nov, 2017 124 pages
2017-2022 North America Alzheimer’s Disease Drug Market Report US$ 4,660.00 US$ 4,100.00

... will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Alzheimer’s Disease Drug in North America market, especially in United States, ... North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...

Nov, 2017 119 pages
2017-2022 India Bacterial Vaginosis Drug Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... , the Bacterial Vaginosis Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the ...

Nov, 2017 124 pages
2017-2022 India Alzheimer’s Disease Drug Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... , the Alzheimer’s Disease Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the ...

Nov, 2017 119 pages
2017-2022 Global Top Countries Bacterial Vaginosis Drug Market Report US$ 4,960.00 US$ 4,365.00

... USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in Global market, especially ... , Middle East and Africa, focuses on the top Players in each country, covering Bayer Pfizer Sanofi Piramal Abbott Galderma Mission Alkem ...

Nov, 2017 124 pages
2017-2022 Global Top Countries Alzheimer’s Disease Drug Market Report US$ 4,960.00 US$ 4,365.00

... USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Alzheimer’s Disease Drug in Global market, especially ... , Middle East and Africa, focuses on the top Players in each country, covering Allergan Eisai Novartis Daiichi Sankyo Merz Pharma Pfizer ...

Nov, 2017 119 pages
2017-2022 Europe Top Countries Bacterial Vaginosis Drug Market Report US$ 4,660.00 US$ 4,100.00

... 2016 and 2022. This report studies Bacterial Vaginosis Drug in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses ...

Nov, 2017 124 pages
2017-2022 Europe Top Countries Alzheimer’s Disease Drug Market Report US$ 4,660.00 US$ 4,100.00

... 2016 and 2022. This report studies Alzheimer’s Disease Drug in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses ...

Nov, 2017 119 pages
2017-2022 China Bacterial Vaginosis Drug Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... . In 2016, the Bacterial Vaginosis Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the ...

Nov, 2017 124 pages
2017-2022 China Alzheimer’s Disease Drug Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... . In 2016, the Alzheimer’s Disease Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the ...

Nov, 2017 119 pages
2017-2022 Asia-Pacific Top Countries Bacterial Vaginosis Drug Market Report US$ 4,660.00 US$ 4,100.00

... xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in Asia-Pacific market, especially in ... Countries, this report splits Asia-Pacific into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...

Nov, 2017 124 pages
2017-2022 Asia-Pacific Top Countries Alzheimer’s Disease Drug Market Report US$ 4,660.00 US$ 4,100.00

... xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Alzheimer’s Disease Drug in Asia-Pacific market, especially in ... Countries, this report splits Asia-Pacific into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...

Nov, 2017 119 pages
US Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review US$ 3,500.00 US$ 2,800.00

... .com provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation ... abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic ...

Nov, 2017 262 pages
UK Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review US$ 2,450.00 US$ 1,960.00

... .com provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation ... abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic ...

Nov, 2017 260 pages
Spain Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review US$ 2,450.00 US$ 1,960.00

... com provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, ... abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic ...

Nov, 2017 260 pages
Japan Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review US$ 2,750.00 US$ 2,200.00

... com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, ... abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic ...

Nov, 2017 260 pages
Italy Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review US$ 2,450.00 US$ 1,960.00

... com provides a comprehensive analysis of the Italian drug of abuse testing market, including emerging tests, technologies, ... abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic ...

Nov, 2017 260 pages
Germany Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review US$ 2,450.00 US$ 1,960.00

... com provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation ... abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic ...

Nov, 2017 262 pages
France Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review US$ 2,450.00 US$ 1,960.00

... com provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation ... abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic ...

Nov, 2017 260 pages
Drugs of Abuse Diagnostics Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review US$ 8,500.00 US$ 6,800.00

... tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic ...

Nov, 2017 318 pages
Global Multiple Sclerosis Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 US$ 4,400.00

Global Multiple Sclerosis Drugs Market: Global multiple sclerosis drugs market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for multiple sclerosis drugs projected to reach US$ XX Mn by 2023. Multiple Sclerosis (MS) is a demyelinating disease that affects ...

Nov, 2017 204 pages
Asia-Pacific Antifungal Drugs Market: By Product Type (Azoles, Allylamines, Echinocandins, Polyenes and Others), By Dosage Forms (Solutions, Tablets & Capsules, Ointments & Creams,... US$ 3,100.00

... healthcare service providers, who are engaged in usage and advocacy of antifungal drugs. Asia-Pacific Antifungal drugs Market: Asia-Pacific antifungal drugs market was valued around US$ 2,500 Mn in 2016 and poised to grow around ...

Oct, 2017 78 pages
Analgesics in the Middle East & Africa US$ 1,325.00

The Middle East & Africa (MEA) was the second-fastest growing market for analgesics over the ... in the region is driven largely by an expanding middle class with more disposable income to spend on OTC ... 2012-2017. Euromonitor International’s Analgesics in the Middle East & Africa global briefing examines the ...

Nov, 2017 58 pages
2017-2022 United States Vitamin & Mineral Supplement Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... the Vitamin & Mineral Supplement market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In United States ... Split by product types/category, covering Multivitamin Single Vitamin Multi Mineral Single Mineral Split by applications/end use ...

Nov, 2017 115 pages
2017 Top 5 Vitamin & Mineral Supplement Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa US$ 4,960.00 US$ 4,365.00

... , revenue and market share from 2012 to 2017, the top players including General Nutrition Centers ... top players in these regions, from 2012 to 2017 (forecast), like North America (United States, Canada ... type, can be divided into Multivitamin Single Vitamin Multi Mineral Single Mineral Split by applications, this ...

Nov, 2017 115 pages
2017-2022 North America Vitamin & Mineral Supplement Market Report US$ 4,660.00 US$ 4,100.00

... reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vitamin & Mineral Supplement in North America market, especially in United States ... splits North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...

Nov, 2017 115 pages
2017-2022 India Vitamin & Mineral Supplement Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... the Vitamin & Mineral Supplement market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India ... by product types/category, covering Multivitamin Single Vitamin Multi Mineral Single Mineral Split by applications/end use industries, covers ...

Nov, 2017 115 pages
2017-2022 Global Top Countries Vitamin & Mineral Supplement Market Report US$ 4,960.00 US$ 4,365.00

... USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vitamin & Mineral Supplement in Global market, especially ... , Middle East and Africa, focuses on the top Players in each country, covering General Nutrition Centers, Inc. AMWAY Puritan’s Pride Pharmavite ...

Nov, 2017 115 pages
2017-2022 Europe Top Countries Vitamin & Mineral Supplement Market Report US$ 4,660.00 US$ 4,100.00

... 2016 and 2022. This report studies Vitamin & Mineral Supplement in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses ...

Nov, 2017 115 pages
2017-2022 China Vitamin & Mineral Supplement Market Report (Status and Outlook) US$ 3,360.00 US$ 2,957.00

... Vitamin & Mineral Supplement market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market ... Pharmaceutical Group Sanofi China Split by product types/category, covering Multivitamin Single Vitamin Multi Mineral Single Mineral Split by ...

Nov, 2017 115 pages
2017-2022 Asia-Pacific Top Countries Vitamin & Mineral Supplement Market Report US$ 4,660.00 US$ 4,100.00

... xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vitamin & Mineral Supplement in Asia-Pacific market, especially in ... Countries, this report splits Asia-Pacific into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...

Nov, 2017 115 pages
GLOBAL OPHTHALMIC DRUGS MARKET FORECAST 2017-2025 US$ 2,500.00 US$ 2,250.00

... market share in the global ophthalmic drugs market. Europe accounts for a second largest market share in the global ophthalmic drugs market. Asia-Pacific is estimated to expand at the highest CAGR during the forecast ...

Nov, 2017 125 pages
Global Transdermal Drug Patch Market Report 2017 US$ 2,350.00

... Section 1 Transdermal Drug Patch Product Definition Section 2 Global Transdermal Drug Patch Market Manufacturer Share and Market Overview 2.1 Global Manufacturer Transdermal Drug Patch Shipments 2.2 Global Manufacturer Transdermal Drug Patch Business Revenue 2.3 Global Transdermal Drug Patch Market Overview ...

Nov, 2017 134 pages
PharmaPoint: Healthcare-Associated Gram-Negative Infections - Global Drug Forecast and Market Analysis to 2026 US$ 10,995.00

PharmaPoint: Healthcare-Associated Gram-Negative Infections - Global Drug Forecast and Market Analysis to 2026 SUMMARY Healthcare-associated infections (HAIs) are a major threat to patient safety, and place a substantial ...

Aug, 2017 379 pages
Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small... US$ 5,650.00

... analyzes the market for various drug discovery services across geographies Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the drug discovery services market

Oct, 2017 170 pages
Global Injectable Drugs Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024 US$ 4,750.00

Global Injectible Drugs Market Outlook Market Overview Drugs which are introduced into body with syringe & needle as a medium is termed as injectible drugs. Among all the approved drugs by Food & Drug Administration (FDA) available ...

Aug, 2017 287 pages
Global Biologics Drug Discovery Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024 US$ 5,750.00

... the global biologics drug discovery market. Delay in government approval for drug discovery and huge investment favoring the shift from market branded drugs to generic drugs are the challenges faced by biologics drug discovery market ...

Sep, 2017 302 pages
Analgesics in Asia Pacific US$ 1,325.00

... population and an increasing preference for topical analgesics over systemics. Looking forward to 2022, Asia Pacific is expected to continue growing at a ... to North America’s USD5.6 billion. Euromonitor International’s Analgesics in Asia Pacific global briefing examines the size, growth trends and potential ...

Oct, 2017 52 pages
NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET FORECAST 2017-2025 US$ 1,250.00 US$ 1,125.00

KEY FINDINGS The North America botanical and plant derivative drug market was valued ... INSIGHTS Several noted vendors in North America are increasingly promoting the deployment of botanical drugs and products as ... drugs. The increasing approval by FDA for botanical drugs and their escalating usage in the regions ...

Oct, 2017 92 pages
GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET FORECAST 2017-2025 US$ 2,500.00 US$ 2,250.00

... by the end of 2025. MARKET INSIGHTS The global market for botanical and plant-derived drugs is chiefly driven by their growing applications in ... terpenes, glycosides, phenols, etc. REGIONAL INSIGHTS The global botanical and plant-derivative drug market is geographically segmented into regions of North America ...

Oct, 2017 145 pages
EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET FORECAST 2017-2025 US$ 1,250.00 US$ 1,125.00

KEY FINDINGS The Europe botanical and plant derivative drug market is predicted to be worth $9217 million by the end of 2025. ... . The various types of botanical and plant derivative drugs include glycosides, steroids, terpenes, and phenols. In order to develop botanical drugs in Europe, the manufacturer has to ...

Oct, 2017 95 pages
ASIA-PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET FORECAST 2017-2025 US$ 1,250.00 US$ 1,125.00

KEY FINDINGS The Asia-Pacific botanical and plant derivative drug market is predicted to rise at 4.10% CAGR over the forecast period of ... steps have been taken towards the adoption of botanical and plant derivative drugs by the governments of other Asia-Pacific countries like Japan, South Korea, China ...

Oct, 2017 98 pages
NORTH AMERICA OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025 US$ 1,250.00 US$ 1,125.00

KEY FINDINGS The North America opioid induced constipation drug market is expected to be the fastest growing market during the ... in 2016 and reach $1382.73 million by 2025. MARKET INSIGHTS The North American OIC drug market is segmented on the basis of the type ...

Aug, 2017 51 pages
NORTH AMERICA IBS-C DRUG MARKET FORECAST 2017-2025 US$ 1,250.00 US$ 1,125.00

KEY FACTORS The North American IBS-c drug market was valued at $439.5 million in 2016. The market is expected to grow at a CAGR of 7.30% and generate $825.07 million by 2025. The ...

Aug, 2017 55 pages
GLOBAL OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025 US$ 2,500.00 US$ 2,250.00

... MARKET INSIGHTS The global Opioid Induced Constipation (OIC) drug market segments include drug type and prescription type. Drug types are further ... strategy adopted by the various market players of global Opioid Induced Constipation (OIC) drug market.The AstraZeneca Pharmaceuticals’s Movantik developed a ...

Aug, 2017 113 pages
GLOBAL IBS-C DRUG MARKET FORECAST 2017-2025 US$ 2,500.00 US$ 2,250.00

... Of these, the North America region is anticipated to dominate the global IBS-C drug market over the forecast period on account of its highly developed healthcare systems and ...

Aug, 2017 112 pages
1 2 3 4 5 >
Skip to top